News - BioPharm International

ADVERTISEMENT

News

MedImmune Signs Cancer Pact with Immunocore

January 9, 2014

MedImmune has entered into a research collaboration with Immunocore to develop novel cancer therapies.

Hemispherx Biopharma Reports Clinical Potential of Treatment for Drug-Resistant Influenza Virus

January 9, 2014

Research was published describing a natural interferon-alpha for infection control and treatment of drug-resistant H7N9 influenza.

FDA Releases Guidance on the Treatment of CABP

January 9, 2014

FDA releases guidance on developing drugs for the treatment of community-acquired bacterial pneumonia.

GE Acquires Cell Culture Media and Sera Assets from Thermo Fisher Scientific

January 6, 2014

GE acquires Thermo Fisher-s HyClone cell culture media and sera products, gene modulation technologies, and magnetic beads businesses.

FDA Announces Voluntary Recall from Abrams Royal Compounding Pharmacy

December 31, 2013

Abrams Royal Pharmacy is recalling all unexpired lots of sterile products dispensed in the US.

AstraZeneca Issues Statement on Competitor to Nexium

December 18, 2013

AstraZeneca issues a statement regarding the launch of esomeprazole strontium in the United States.

Biogen Idec, Samsung Bioepis Target Anti-TNF Biosimilars in Europe

December 18, 2013

Biogen and Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, advance plans for anti-TNF biosimilar product candidates.

FDA and European Medicines Agency Announce Generic-Drug Application Inspections Initiative

December 18, 2013

FDA and EMA launch initiative to share bioequivalence inspection information.

Pfizer, Teva Settle Patent Litigation on Viagra

December 18, 2013

Pfizer settles its litigation against Teva Pharmaceuticals regarding Pfizer's patent covering the use of Viagra.

ADVERTISEMENT

ADVERTISEMENT

Click here